Episode 46 – Anticoagulation in Atrial Fibrillation

Welcome back Rounds Table Listeners!

We are back today with our Classic Rapid Fire Podcast!

This week, Drs. John and Mike Fralick discuss two recent papers – one, exploring the use of rivaroxaban in rheumatic heart-disease associated atrial fibrillation, and the second investigating the effect of reduced-dose edoxaban on clinical outcomes in elderly individuals with atrial fibrillation. Two papers, here we go!

  1. Effect of 15-mg Edoxaban on Clinical Outcomes in 3 Age Strata in Older Adults with Atrial Fibrillation (0:00 – 6:42).

  2. Rivaroxaban in Rheumatic Heart Disease-Associated Atrial Fibrillation (6:42 – 17:11).

And for the Good Stuff:

Questions? Comments? Feedback? We’d love to hear from you! @roundstable

Leave a Comment

Your email address will not be published. Required fields are marked *

Republish this article

Republish this article on your website under the creative commons licence.

Learn more